Pharmaceutical compositions comprising POH derivatives
The present invention provides for a derivative of monoterpene or sesquiterpene, such as a perillyl alcohol derivative. For example, the perillyl alcohol derivative may be a perillyl alcohol carbamate. The perillyl alcohol derivative may be perillyl alcohol conjugated with a therapeutic agent such as a chemotherapeutic agent. The present invention also provides for a method of treating a disease such as cancer, comprising the step of delivering to a patient a therapeutically effective amount of a derivative of monoterpene (or sesquiterpene). The route of administration may vary, and can include, inhalation, intranasal, oral, transdermal, intravenous, subcutaneous or intramuscular injection.
1. A method for treating a tumor of the central nervous system in a mammal, comprising the step of administering to the mammal a therapeutically effective amount of a perillyl alcohol carbamate, wherein the perillyl alcohol carbamate comprises perillyl alcohol conjugated with rolipram and wherein a tumor of the central nervous system is selected from the group consisting of glioblastoma and astrocytoma.
2. The method of claim 1 , wherein the perillyl alcohol carbamate is administered using a nasal delivery device.
3. The method of claim 1 , further comprising the step of treating the mammal with radiation.
4. The method of claim 1 , further comprising the step of delivering to the mammal a chemotherapeutic agent.
5. The method of claim 1 , wherein the perillyl alcohol carbamate is 4-(3-cyclopentyloxy-4-methoxy phenyl)-2-oxo-pyrrolidine-1-carboxylic acid 4-isopropenyl cyclohex-1-enylmethyl ester.
6. The method of claim 2 , wherein the nasal delivery device is selected from the group consisting of an intranasal inhaler, an intranasal spray device, an atomizer, a nebulizer, a metered dose inhaler (MDI), a pressurized dose inhaler, an insufflator, a unit dose container, a pump, a dropper, a nasal spray bottle, a squeeze bottle and a bi-directional device.
7. A method for inhibiting or decreasing growth of a tumor cell of the nervous central system, the method comprising contacting the tumor cell with an effective amount of a perillyl alcohol carbamate, wherein the perillyl alcohol carbamate perillyl alcohol conjugated with rolipram and wherein the tumor cell is selected from the group consisting of glioblastoma and astrocytoma.
8. The method of claim 7 , wherein the perillyl alcohol carbamate is 4-(3-cyclopentyloxy-4-methoxy phenyl)-2-oxo-pyrrolidine-1-carboxylic acid 4-isopropenyl cyclohex-1-enylmethyl ester.